|
Dermtech Inc (NASDAQ: DMTK) |
|
Dermtech Inc
DMTK's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Dermtech Inc growth rates, revenue grew
by 24.01 % in the first quarter of 2024 from the same quarter a year ago.
Ranking at No. 1580
Medical Laboratories industry recorded
growth of revenues by 2.69 %
Dermtech Inc net loss decreased from $-28 millions, to $-20 millions in first quarter of 2024,
• More on DMTK's Growth
|
|
Dermtech Inc realized a net loss in trailing twelve months.
Dermtech Inc realized cash reduction of $ -1.43 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.24.
Medical Laboratories industry's Price to Sales ratio is at 2.26.
• More on DMTK's Valuation
|
|
|
|
|
Dermtech Inc realized net loss in trailing twelve months.
Dermtech Inc realized cash outflow of $ -1.43per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.24.
Medical Laboratories industry's Price to Sales ratio is at 2.26.
Dermtech Inc Price to Book Ratio is at 0.08 lower than Industry Avg. of 329.69. and higher than S&P 500 Avg. of 0.01
• More on DMTK's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com